344 related articles for article (PubMed ID: 29388206)
1. Fraction and incidence of liver cancer attributable to hepatitis B and C viruses worldwide.
Maucort-Boulch D; de Martel C; Franceschi S; Plummer M
Int J Cancer; 2018 Jun; 142(12):2471-2477. PubMed ID: 29388206
[TBL] [Abstract][Full Text] [Related]
2. Worldwide prevalence of hepatitis B virus and hepatitis C virus among patients with cirrhosis at country, region, and global levels: a systematic review.
Alberts CJ; Clifford GM; Georges D; Negro F; Lesi OA; Hutin YJ; de Martel C
Lancet Gastroenterol Hepatol; 2022 Aug; 7(8):724-735. PubMed ID: 35576953
[TBL] [Abstract][Full Text] [Related]
3. Burden of virus-associated liver cancer in the Arab world, 1990-2010.
Khan G; Hashim MJ
Asian Pac J Cancer Prev; 2015; 16(1):265-70. PubMed ID: 25640363
[TBL] [Abstract][Full Text] [Related]
4. Epidemiology, risk factors, and natural history of hepatocellular carcinoma.
Montalto G; Cervello M; Giannitrapani L; Dantona F; Terranova A; Castagnetta LA
Ann N Y Acad Sci; 2002 Jun; 963():13-20. PubMed ID: 12095924
[TBL] [Abstract][Full Text] [Related]
5. Multiplicative synergistic risk of hepatocellular carcinoma development among hepatitis B and C co-infected subjects in HBV endemic area: a community-based cohort study.
Oh JK; Shin HR; Lim MK; Cho H; Kim DI; Jee Y; Yun H; Yoo KY
BMC Cancer; 2012 Oct; 12():452. PubMed ID: 23039099
[TBL] [Abstract][Full Text] [Related]
6. World-wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma.
de Martel C; Maucort-Boulch D; Plummer M; Franceschi S
Hepatology; 2015 Oct; 62(4):1190-200. PubMed ID: 26146815
[TBL] [Abstract][Full Text] [Related]
7. Primary liver cancer deaths and related years of life lost attributable to hepatitis B and C viruses in India.
Islami F; Dikshit R; Mallath MK; Jemal A
Cancer Epidemiol; 2016 Feb; 40():79-86. PubMed ID: 26683034
[TBL] [Abstract][Full Text] [Related]
8. Next big threat for Pakistan Hepatocellular Carcinoma (HCC).
Parkash O; Hamid S
J Pak Med Assoc; 2016 Jun; 66(6):735-9. PubMed ID: 27339578
[TBL] [Abstract][Full Text] [Related]
9. Hepatocellular carcinoma: Clinical-pathological features and HIV infection in Mozambican patients.
Cunha L; Carrilho C; Bhatt N; Loforte M; Maueia C; Fernandes F; Guisseve A; Mbofana F; Maibaze F; Mondlane L; Ismail M; Dimande L; Machatine S; Lunet N; Liu YT; Gudo ES; Pineau P
Cancer Treat Res Commun; 2019; 19():100129. PubMed ID: 30903933
[TBL] [Abstract][Full Text] [Related]
10. A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.
Zhang JY; Dai M; Wang X; Lu WQ; Li DS; Zhang MX; Wang KJ; Dai LP; Han SG; Zhou YF; Zhuang H
Int J Epidemiol; 1998 Aug; 27(4):574-8. PubMed ID: 9758109
[TBL] [Abstract][Full Text] [Related]
11. Incidence of hepatocellular carcinoma among older Americans attributable to hepatitis C and hepatitis B: 2001 through 2013.
Shiels MS; Engels EA; Yanik EL; McGlynn KA; Pfeiffer RM; O'Brien TR
Cancer; 2019 Aug; 125(15):2621-2630. PubMed ID: 30980394
[TBL] [Abstract][Full Text] [Related]
12. Mortality from liver diseases attributable to hepatitis B and C in the EU/EEA - descriptive analysis and estimation of 2015 baseline.
Mårdh O; Quinten C; Amato-Gauci AJ; Duffell E
Infect Dis (Lond); 2020 Sep; 52(9):625-637. PubMed ID: 32644030
[No Abstract] [Full Text] [Related]
13. Impact of HBV, HCV and GBV-C/HGV on hepatocellular carcinomas in Europe: results of a European concerted action.
Bréchot C; Jaffredo F; Lagorce D; Gerken G; Meyer zum Büschenfelde K; Papakonstontinou A; Hadziyannis S; Romeo R; Colombo M; Rodes J; Bruix J; Williams R; Naoumov N
J Hepatol; 1998 Aug; 29(2):173-83. PubMed ID: 9722197
[TBL] [Abstract][Full Text] [Related]
14. Viral hepatitis associated hepatocellular carcinoma on the African continent, the past, present, and future: a systematic review.
Dakurah OB; Tamandjou CRT; Zunza M; Preiser W; Maponga TG
BMC Cancer; 2021 Jun; 21(1):715. PubMed ID: 34144696
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B and C viruses and survival from hepatocellular carcinoma in the Arkhangelsk region: a Russian registry-based study.
Makarova M; Krettek A; Valkov MY; Grjibovski AM
Int J Circumpolar Health; 2013; 72():20282. PubMed ID: 23687637
[TBL] [Abstract][Full Text] [Related]
16. Comparison of viral hepatitis-associated hepatocellular carcinoma due to HBV and HCV - cohort from liver clinics in Pakistan.
Munaf A; Memon MS; Kumar P; Ahmed S; Kumar MB
Asian Pac J Cancer Prev; 2014; 15(18):7563-7. PubMed ID: 25292029
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.
Suga M; Senota A; Arima K; Kodama T; Ikuta S; Sakamoto H; Ohe Y; Sugai S; Yachi A
Hepatogastroenterology; 1994 Oct; 41(5):438-41. PubMed ID: 7531667
[TBL] [Abstract][Full Text] [Related]
18. Comparative analysis of HBV and HCV infection in hepatocellular carcinoma and chronic liver disease--an autopsy based study.
Vaiphei K; Pal NS; Arora SK
Indian J Pathol Microbiol; 2006 Jul; 49(3):357-61. PubMed ID: 17001884
[TBL] [Abstract][Full Text] [Related]
19. Minor role of hepatitis B and C virus infection in the etiology of hepatocellular carcinoma in a low-endemic area.
Kaczynski J; Hansson G; Hermodsson S; Olsson R; Wallerstedt S
Scand J Gastroenterol; 1996 Aug; 31(8):809-13. PubMed ID: 8858752
[TBL] [Abstract][Full Text] [Related]
20. Global incidence and mortality of hepatitis B and hepatitis C acute infections, cirrhosis and hepatocellular carcinoma from 2010 to 2019.
Veracruz N; Gish RG; Cheung R; Chitnis AS; Wong RJ
J Viral Hepat; 2022 May; 29(5):352-365. PubMed ID: 35274406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]